Pfizer quarterly revenue declines two percent. Another AstraZeneca offer in the works?

Comment icon 0 Comments
With potential acquisitions hovering in the background, drugmaker Pfizer said Tuesday that its third-quarter revenue declined two percent from... Read more

Merck total sales revenue declines in third quarter

Comment icon 0 Comments
Drugmaker Merck & Co., said Monday morning that its total revenue declined four percent in the third quarter of this year compared to the... Read more

$54 billion AbbVie-Shire deal effectively dead

Comment icon 0 Comments
AbbVie's board of directors essentially pulled the plug on the drugmaker's $54 billion acquisition of Shire Pharmaceuticals because of tougher... Read more

With taxes in mind, AbbVie says it might not buy Shire

Comment icon 0 Comments
One of the more prominent tax inversion-prompted corporate takeovers appears to be coming undone because the U.S. Treasury Department stepped... Read more

J&J's revenue up, but near flat sales growth in medical devices, hepatitis C competition

Comment icon 0 Comments
Healthcare giant Johnson & Johnson reported third quarter financial results Tuesday morning, with sales increasing to $18.5 billion, 5.1... Read more

Teva won't say how many layoffs go with pipeline cuts in oncology and women's health

Comment icon 0 Comments
Teva Pharmaceuticals would not say Monday afternoon on how many people lose jobs in the wake of Monday morning's announcement that it will... Read more

Can the US control high-priced drugs? Pharma-connected doc gingerly walks up to the issue

Comment icon 0 Comments
How do you define - and price - value and benefit? In an article posted Friday on the Journal of American Medical Association website (free... Read more

Shire to pay $56.5 million to settle allegations it inappropriately promoted ADHD drugs

Comment icon 0 Comments
Shire Pharmaceuticals L.L.C. will pay $56.5 million to settle allegations that it inappropriately promoted the sale of ADHD medicine, among other... Read more